Provider Liability Concerns with Changes to the CDC Childhood Immunization Schedule
This blog entry includes a summary of the talking points from “Navigating Conflicting Vaccination Recommendations: Guidance for Clinicians,” published in JAMA.
Birthing Institutions and the Vaccines for Children Program
This handout outlines how birthing institution participation in VFC can ensure equitable access to vaccines, save money, and protect newborns from RSV and hepatitis B.
What’s Happening with Aluminum?
Likely you’ve heard some back-and-forth recently about the use of aluminum as an adjuvant in vaccines. Here’s what you need to know from both sides of the argument.
FDA Gives Approval to Moderna’s Spikevax COVID-19 Vaccine for Children 6 Months Through 11 years… But Only If at High Risk
On July 9, 2025, the FDA released its decision to approve the supplemental Biologics License Application (BLA) for SPIKEVAX, but only for certain ages at high risk.
What To Know About the Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season Study
Here’s what you need to know about the study, Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season.
American Academy of Pediatrics (AAP) Chapter Immunization Representatives (CIRs)
The American Academy of Pediatrics (AAP) is updating the roster of Chapter Immunization Representatives (CIRs) and is seeking to maintain an updated listing.
Does Early MMR Vaccination Lead to Reduced Protection Against Measles?
A look at a recent study, Long-term Dynamics of Measles Virus–Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age.
COVID-19 Pediatric Vaccination Commercialization Listening Sessions Report
AIM held eight listening sessions with immunization PMs during the VAC Regional Meetings for adult immunization from May-July 2024.
Request for Interest Forms: Community of Practice to Optimize Administration of Birth Dose Immunizations
AIM invites participation in its Immunization Program and Birthing Institution Community of Practice (CoP) to Optimize Administration of Birth Dose Immunizations.
January 2025 Study Finds Children Ages 0 to 35 month Received at Least One Invalid Vaccine Dose
A study found that 15.4% of children ages 0 to 35 months received at least one invalid vaccine dose.